Trinity Biotech plc is a public company (NASDAQ: TRIB) with manufacturing facilities in Bray, Ireland, Jamestown, New York and Carlsbad, California.

    The company specialises in the development, manufacture and marketing of diagnostic products which utilise immunoassay technologies. Trinity markets over 120 products through distributors in 80 countries.

    The company was formed in 1992 and attained its first full year of profit in 1997. Trinity Biotech has expanded through a combination of internal and acquisition-led growth. Trinity's major developments are as follows:

    March 1994 Acquired Disease Detection International of Irvine, California

    July 1996 Launched Uni-Gold™HIV and Uni-Gold™Hep B One-step tests

    February 1997 Acquired Clark Laboratories, Jamestown New York

    July 1997 Acquired Centocor UK

    March 1998 Opened new 50,000 sq. ft. manufacturing facility in Bray, Co. Wicklow

    May 1998 Launched Enteric range of products

    June 1998 Acquired the Hormone and Drugs of Abuse product lines from Diatech, Boston

    July 1998 Acquired Macra甃p(a) product from Strategic Diagnostics Inc.

    September 1998 Acquired HIV product line from Cambridge Diagnostics

    October 1998 Trinity acquired the MicroTrak畃roduct line from Dade Behring

    March 2000 Trinity acquired MarDx瓺iagnostics, Inc.

    October 2000 Trinity invests in genomics company, HiberGen Ltd.

    December 2000 Trinity acquired assets and goodwill of Bartels Inc.

    October 2001 Trinity establishes German subsidiary

    December 2001 Trinity acquires Biopool hemostasis business

    August 2002 Trinity Biotech completes acquisition of Hemostasis Division of Sigma Diagnostics

    December 2002 Trinity Biotech acquires the Specialty Clinical Chemistry business from Sigma Diagnostics

    Through a combination of in-house R & D and acquisitions, the company has assembled an impressive product portfolio and achieved an excellence in developing, manufacturing and marketing quality products that meet market demands. Its product range utilises immunoassay techniques, which have been employed to develop tests in five main formats. One-step rapid tests which utilise the company's proprietary Uni-Gold™Technology, multiple tests on Microtitre plates, Western Blot, immunofluorescence and coagulation